Medicenna Therapeutics Corp (MDNAF)

$0.59 -0.01 (-2.15%)
Market Cap 50.05M
Revenue (ttm) 0.00
Net Income (ttm) -8.48M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 51,900
Avg Vol 128,934
Day's Range N/A - N/A
Shares Out 83.41M
Stochastic %K 7%
Beta 1.81
Analysts Strong Sell
Price Target $2.96

Company Profile

Medicenna Therapeutics Corp., a clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases. It develops bizaxofusp, an interleukin- 4 (IL-4) targeted therapy for the treatment of recurrent glioblastoma. The company also develops MDNA11, a long-acting interleukin-2 (IL-2) to activate anti-cancer immune cells over immunosuppressive Tregs; MDNA209, an IL-2/IL-15...

Industry: Biotechnology
Sector: Healthcare
Phone: 416 648 5555
Address:
2 Bloor Street West, Suite 903 7th Floor, Toronto, Canada
_Osmium
_Osmium May. 12 at 11:19 AM
$MDNAF Today's press release was standard practice but now Dr. Merchant can focus elsewhere. I find that significant. Here is the quote: “Dosing the first patient in the NEO-CYT study represents an important milestone in the continued clinical development of MDNA11 and expands our evaluation of this next-generation IL-2 Superkine into the neoadjuvant setting,” said Dr. Nageatte Ibrahim, Chief Medical Officer of Medicenna.
1 · Reply
Itsybitsybeanbag
Itsybitsybeanbag May. 12 at 11:18 AM
$MDNAF Great seeing some comments from the rock-star CMO Dr. Nageatte Ibrahim!!!
1 · Reply
Itsybitsybeanbag
Itsybitsybeanbag May. 12 at 11:09 AM
$MDNAF Neo-Cyt Begins! Results should start rolling in a few months!! https://ir.medicenna.com/news-releases/news-release-details/medicenna-and-fondazione-melanoma-onlus-announce-first-patient
1 · Reply
Biotech_Pharma_Investor
Biotech_Pharma_Investor May. 11 at 7:47 PM
$MDNAF Hopefully a good-priced offering coming? Or pump before the offering...
0 · Reply
Lytnup
Lytnup May. 11 at 6:46 PM
$MDNAF Only need another 10 days like this to get back to the 52-week high…..not saying that’s where it should stay, but just sayin’…..
2 · Reply
Itsybitsybeanbag
Itsybitsybeanbag May. 11 at 6:38 PM
$MDNAF and down she goes….
0 · Reply
rudazur2
rudazur2 May. 11 at 6:00 PM
$MDNAF asco in 3 weeks or future offering take your bet for today action move
0 · Reply
Lytnup
Lytnup May. 11 at 5:47 PM
$MDNAF have to admit, it’s kind of fun to watch; not very often do I see the bid above the ask, & last trade above both…..
0 · Reply
Vikingess
Vikingess May. 11 at 3:02 PM
$MDNAF why is this "up" today?
2 · Reply
Lytnup
Lytnup May. 11 at 2:23 PM
$MDNAF It’s been a bit since I have seen this for any ticker symbol
0 · Reply
Latest News on MDNAF
No data available.
_Osmium
_Osmium May. 12 at 11:19 AM
$MDNAF Today's press release was standard practice but now Dr. Merchant can focus elsewhere. I find that significant. Here is the quote: “Dosing the first patient in the NEO-CYT study represents an important milestone in the continued clinical development of MDNA11 and expands our evaluation of this next-generation IL-2 Superkine into the neoadjuvant setting,” said Dr. Nageatte Ibrahim, Chief Medical Officer of Medicenna.
1 · Reply
Itsybitsybeanbag
Itsybitsybeanbag May. 12 at 11:18 AM
$MDNAF Great seeing some comments from the rock-star CMO Dr. Nageatte Ibrahim!!!
1 · Reply
Itsybitsybeanbag
Itsybitsybeanbag May. 12 at 11:09 AM
$MDNAF Neo-Cyt Begins! Results should start rolling in a few months!! https://ir.medicenna.com/news-releases/news-release-details/medicenna-and-fondazione-melanoma-onlus-announce-first-patient
1 · Reply
Biotech_Pharma_Investor
Biotech_Pharma_Investor May. 11 at 7:47 PM
$MDNAF Hopefully a good-priced offering coming? Or pump before the offering...
0 · Reply
Lytnup
Lytnup May. 11 at 6:46 PM
$MDNAF Only need another 10 days like this to get back to the 52-week high…..not saying that’s where it should stay, but just sayin’…..
2 · Reply
Itsybitsybeanbag
Itsybitsybeanbag May. 11 at 6:38 PM
$MDNAF and down she goes….
0 · Reply
rudazur2
rudazur2 May. 11 at 6:00 PM
$MDNAF asco in 3 weeks or future offering take your bet for today action move
0 · Reply
Lytnup
Lytnup May. 11 at 5:47 PM
$MDNAF have to admit, it’s kind of fun to watch; not very often do I see the bid above the ask, & last trade above both…..
0 · Reply
Vikingess
Vikingess May. 11 at 3:02 PM
$MDNAF why is this "up" today?
2 · Reply
Lytnup
Lytnup May. 11 at 2:23 PM
$MDNAF It’s been a bit since I have seen this for any ticker symbol
0 · Reply
Pramdizzle
Pramdizzle May. 10 at 9:40 PM
$MDNAF is the asymmetric upside still present here? I have a small position. Others holding for an upcoming catalyst?
0 · Reply
bobwut12
bobwut12 May. 7 at 8:23 PM
$MDNAF I feel like the price is inversely proportional to the amount that David writes about their science.
0 · Reply
Lytnup
Lytnup May. 7 at 3:39 PM
$MDNAF Mr. Bakke has been busy https://open.substack.com/pub/davidbakke/p/the-illusion-of-control-part-1-when?r=10wt7d&utm_medium=ios https://open.substack.com/pub/davidbakke/p/prism-11-key-refractions-the-illusion?r=10wt7d&utm_medium=ios
1 · Reply
Lytnup
Lytnup May. 7 at 12:09 PM
$MDNAF Never heard of Locust Walks, but their new venture sounds timely…… https://www.linkedin.com/posts/andy-meyerson-1036562_todaywereproud-to-announce-the-launch-activity-7457454578184187904-ufDQ?utm_medium=ios_app&rcm=ACoAAAsnC8EBAcKQyUEEvVrkPzTEpnlOSa2bgnk&utm_source=social_share_send&utm_campaign=copy_link
1 · Reply
Lytnup
Lytnup May. 6 at 7:57 PM
$MDNAF Tangential information, but may help add some color to this ever-evolving company https://substack.com/@stocktherapywithpennyqueen/note/p-196602544?r=10wt7d&utm_medium=ios&utm_source=notes-share-action https://substack.com/@david132748/note/p-196009270?r=10wt7d&utm_medium=ios&utm_source=notes-share-action https://substack.com/@david132748/note/p-196014928?r=10wt7d&utm_medium=ios&utm_source=notes-share-action
0 · Reply
rudazur2
rudazur2 May. 6 at 12:45 AM
$MDNAF 250M offer for full buyout like that this shit stock is finish 😂
1 · Reply
Brocseg3
Brocseg3 May. 3 at 9:40 PM
$MDNAF Very insightful article, thanks for sharing.
1 · Reply
Lytnup
Lytnup May. 2 at 3:54 PM
$MDNAF While we wait for ASCO, I decided to take a closer look at Dr. Ibrahim’s consultant firm, Arc Nouvel, largely because I am still wondering why she would involve herself (even as a “fractional” CMO) in a small drug development company that is facing a funding cliff….. There are a number of interesting articles authored by her partners under the “News” tab - none mention Medicenna (that I could see), but many of the ideas discussed in this one seem quite germane to the company’s current state, and raise questions that would be very interesting to hear answered by Dr. Merchant. https://arcnouvel.com/who-is-arc-nouvel-dr-vivian-li-on-strategy-risk-and-value-in-clinical-development/
1 · Reply
NewbJackCity
NewbJackCity May. 1 at 9:47 PM
$MDNAF I’ve been out of the loop for a bit. Anyone know what happened to mdna11 phase 2 data? Are we getting close, did it pass me by?
0 · Reply
Dipper2013
Dipper2013 Apr. 30 at 3:58 PM
$MDNAF they are selling stock to pay bills.. sad..
1 · Reply
_Osmium
_Osmium Apr. 30 at 11:45 AM
$MDNAF Going to ASCO this year. Very nice. https://ir.medicenna.com/news-releases/news-release-details/medicenna-and-fondazione-melanoma-onlus-announce-presentation
0 · Reply
boomshiva
boomshiva Apr. 29 at 1:39 PM
$MDNAF I really should stay away from Canadian stocks.......they're the most bipolar stocks I've ever owned.! Updated new year's resolution: sell all at $17.00. No matter what.
2 · Reply